Font Size: a A A
Keyword [transferrin]
Result: 181 - 200 | Page: 10 of 10
181. Transferrin receptor targeted delivery of siRNA for gene therap
182. Trafficking of hydrolysis-prone metals titanium(IV) and iron(III) by serum proteins and models
183. Disordered iron regulation in manganese Parkinsonism: Roles of divalent metal transporter 1, metal transporter protein 1 and transferrin receptor in the blood-CSF barrier
184. Characterization of structural changes and large-scale protein dynamics and their influence on metal ion binding by human serum transferrin by ESI MS
185. Characterization of potential interactions between transferrin binding proteins in Neisseria gonorrhoeae
186. Design of Nanoparticles That Cross the Blood-Brain Barrier by Receptor Mediated Transcytosis
187. Placental transferrin receptor 1, fetal tissue iron, and renal development in different etiologies of intrauterine growth restriction
188. Anti-transferrin receptor IgG3 -avidin fusion proteins as universal drug delivery systems and direct tumoricidal agents for the treatment of hematopoietic malignancies
189. Factors disturbing the oxidant-antioxidant balance in diabetes mellitus: Role of iron
190. Characterization of the role of the c-MYC target gene transferrin receptor 1 (TFRC1) in cellular proliferation
191. Design of folic acid, transferrin, and integrin receptor specific polyamidoamine dendrimers for gene delivery
192. Regulation of survival, proliferation, and self -renewal of multipotent neural progenitors: Roles for insulin, transferrin, and PTEN
193. Production and characterization of proinsulin-transferrin fusion protein
194. The kinetics of iron removal from human serum transferrin by diphosphonates and phosphonocarboxylate ligands
195. Linkers in transferrin fusion proteins: Effects on pharmacokinetics and pharmacodynamics
196. Biology and receptor interactions ofp97 and the transferrin receptors
197. Computational studies of the metal-binding proteins stromelysin-1 and human serum transferrin: Protein modeling and inhibitor design
198. Effect of blood elements on bacterial adhesion to biomaterials
199. Design and characterization of a membrane-active GALA-OKT9 conjugate and its effect on transferrin-gelonin immunotoxin efficacy
200. Insulin-transferrin conjugate as an oral hypoglycemic agent
  <<First  <Prev  Next>  Last>>  Jump to